These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28517963)

  • 21. Vaccination against hepatitis B in patients on chronic haemodialysis.
    Kovacic V
    Int J Clin Pract; 2003 Apr; 57(3):161-2. PubMed ID: 12723714
    [No Abstract]   [Full Text] [Related]  

  • 22. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
    Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
    Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of the hepatitis B virus S‑ecdCD40L vaccine therapy in HBV transgenic mice: A vaccine‑induced activation of antigen presenting dendritic cells.
    Guan H; Lan S; Wu J; Tang B; Xu Y
    Mol Med Rep; 2017 Nov; 16(5):6102-6108. PubMed ID: 28849136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulation, characterization and optimization of hepatitis B surface antigen (HBsAg)-loaded chitosan microspheres for oral delivery.
    Premaletha K; Licy CD; Jose S; Saraladevi A; Shirwaikar A; Shirwaikar A
    Pharm Dev Technol; 2012; 17(2):251-8. PubMed ID: 21108582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New vaccination strategies for low- and non-responders to hepatitis B vaccine.
    Rendi-Wagner P; Wiedermann G; Stemberger H; Kollaritsch H
    Wien Klin Wochenschr; 2002 Mar; 114(5-6):175-80. PubMed ID: 12238305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delivery of immunoreactive antigen using a controllable needle-free jet injector.
    Hogan NC; Anahtar MN; Taberner AJ; Hunter IW
    J Control Release; 2017 Jul; 258():73-80. PubMed ID: 28479095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
    Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
    Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
    Betancourt AA; Delgado CA; Estévez ZC; Martínez JC; Ríos GV; Aureoles-Roselló SR; Zaldívar RA; Guzmán MA; Baile NF; Reyes PA; Ruano LO; Fernández AC; Lobaina-Matos Y; Fernández AD; Madrazo AI; Martínez MI; Baños ML; Alvarez NP; Baldo MD; Mestre RE; Pérez MV; Martínez ME; Escobar DA; Guanche MJ; Cáceres LM; Betancourt RS; Rando EH; Nieto GE; González VL; Rubido JC
    Int J Infect Dis; 2007 Sep; 11(5):394-401. PubMed ID: 17257877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cloning, protein expression and immunogenicity of HBs-murine IL-18 fusion DNA vaccine.
    Channarong S; Mitrevej A; Sinchaipanid N; Usuwantim K; Kulkeaw K; Chaicumpa W
    Asian Pac J Allergy Immunol; 2007 Dec; 25(4):233-42. PubMed ID: 18402297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overcoming HBV immune tolerance to eliminate HBsAg-positive hepatocytes via pre-administration of GM-CSF as a novel adjuvant for a hepatitis B vaccine in HBV transgenic mice.
    Wang X; Dong A; Xiao J; Zhou X; Mi H; Xu H; Zhang J; Wang B
    Cell Mol Immunol; 2016 Nov; 13(6):850-861. PubMed ID: 26166767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Waning immunity and booster responses in nursing and medical technology students who had received plasma-derived or recombinant hepatitis B vaccine during infancy.
    Lin CC; Yang CY; Shih CT; Chen BH; Huang YL
    Am J Infect Control; 2011 Jun; 39(5):408-414. PubMed ID: 21255876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B vaccines: protective efficacy and therapeutic potential.
    Michel ML; Tiollais P
    Pathol Biol (Paris); 2010 Aug; 58(4):288-95. PubMed ID: 20382485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seroprotection after hepatitis B vaccination in children aged 1 to 15 years in central province of Iran, Semnan.
    Rezaei M; Nooripoor S; Ghorbani R; Ramezanshams F; Mamishi S; Mahmoudi S
    J Prev Med Hyg; 2014 Mar; 55(1):1-3. PubMed ID: 25916024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18-55 years of age.
    Halperin SA; Ward B; Cooper C; Predy G; Diaz-Mitoma F; Dionne M; Embree J; McGeer A; Zickler P; Moltz KH; Martz R; Meyer I; McNeil S; Langley JM; Martins E; Heyward WL; Martin JT
    Vaccine; 2012 Mar; 30(15):2556-63. PubMed ID: 22326642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HBV-ISS (Dynavax).
    Sung JJ; Lik-Yuen H
    Curr Opin Mol Ther; 2006 Apr; 8(2):150-5. PubMed ID: 16610768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase 1 safety and immune response studies of a DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device.
    Tacket CO; Roy MJ; Widera G; Swain WF; Broome S; Edelman R
    Vaccine; 1999 Jul; 17(22):2826-9. PubMed ID: 10438052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Booster hepatitis B vaccination not necessary for long-term protection in children immunised with hexavalent vaccines.
    Romanò L; Zanetti AR
    J Prev Med Hyg; 2011 Jun; 52(2):45-6. PubMed ID: 21842704
    [No Abstract]   [Full Text] [Related]  

  • 38. The Last Ten Years of Advancements in Plant-Derived Recombinant Vaccines against Hepatitis B.
    Joung YH; Park SH; Moon KB; Jeon JH; Cho HS; Kim HS
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27754367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B vaccination.
    Romanò L; Paladini S; Galli C; Raimondo G; Pollicino T; Zanetti AR
    Hum Vaccin Immunother; 2015; 11(1):53-7. PubMed ID: 25483515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B: review of development from the discovery of the "Australia Antigen" to end of the twentieth Century.
    Yap SF
    Malays J Pathol; 2004 Jun; 26(1):1-12. PubMed ID: 16190102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.